These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29021458)

  • 21. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the efficacy of ceftriaxone in acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media. A comparative study with cefotiam as the control].
    Baba S; Mori Y; Suzuki K; Unno T; Kawabori S; Yanai T; Nonaka S; Takasaka T; Awataguchi T; Furuuchi I
    Jpn J Antibiot; 1989 Jan; 42(1):212-47. PubMed ID: 2523493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
    Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
    Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
    Tasic V; Sofijanova A; Avramoski V
    Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
    [No Abstract]   [Full Text] [Related]  

  • 25. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ceftriaxone as a single agent in empirical therapy of infection in patients with hematologic disorders. Hanshin Infection Study Group].
    Kuyama J; Yonezawa T; Kageyama T; Ohyabu H; Kitani T; Taniguchi N; Masaoka T; Shibata H; Yasunaga K; Fujitake H
    Jpn J Antibiot; 1989 Apr; 42(4):930-7. PubMed ID: 2671427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of ceftriaxone against infections in the field of obstetrics and gynecology].
    Chimura T; Morisaki N; Matsuo M
    Jpn J Antibiot; 1988 Jun; 41(6):641-5. PubMed ID: 3221429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
    Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
    Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
    Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
    Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation on ceftriaxone in the pediatric field].
    Nakazawa S; Satoh H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K
    Jpn J Antibiot; 1984 Nov; 37(11):2083-101. PubMed ID: 6098703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of ceftriaxone on infections during the perinatal period].
    Chimura T; Watanabe T; Oda T
    Jpn J Antibiot; 1988 Mar; 41(3):306-11. PubMed ID: 3404648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on ceftriaxone in complicated urinary tract infections].
    Yamakawa K; Hioki T; Kawamura J
    Hinyokika Kiyo; 1989 Feb; 35(2):377-82. PubMed ID: 2735247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases.
    Araz N; Okan V; Demirci M; Araz M
    Tohoku J Exp Med; 2007 Mar; 211(3):285-90. PubMed ID: 17347554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study.
    Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S
    Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone-associated biliary pseudolithiasis in paediatric surgical patients.
    Ceran C; Oztoprak I; Cankorkmaz L; Gumuş C; Yildiz T; Koyluoglu G
    Int J Antimicrob Agents; 2005 Mar; 25(3):256-9. PubMed ID: 15737522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible ceftriaxone-associated biliary pseudolithiasis in children.
    Schaad UB; Wedgwood-Krucko J; Tschaeppeler H
    Lancet; 1988 Dec; 2(8625):1411-3. PubMed ID: 2904533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis.
    Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD
    Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.